Financing focused on domestic biomanufacturing capacity and capabilities for biologics, vaccines, and nucleic acids SAN…
Management to host conference call and webcast at 4:30 p.m. ET IRVINE, Calif., March 23,…
VersaClimber available in simple monthly payments, with no hidden or late fees SAN FRANCISCO–(BUSINESS WIRE)–Affirm…
‘Mindful by Lucy’ Mushroom Microdose Supplements VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) —…
‘Mindful by Lucy’ Mushroom Microdose Supplements VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) —…
Additional poster presentation to detail high-dose cohort safety data from Phase 2a trial of tegoprubart…
Additional poster presentation to detail high-dose cohort safety data from Phase 2a trial of tegoprubart…
WESTLAKE VILLAGE, Calif., March 23, 2023 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX) (“Genelux” or…
WESTLAKE VILLAGE, Calif., March 23, 2023 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX) (“Genelux” or…
Validive® Phase 2b/3 VOICE Trial Anticipates Go/No-Go Interim Readout by End of Next WeekCamsirubicin Phase…
Validive® Phase 2b/3 VOICE Trial Anticipates Go/No-Go Interim Readout by End of Next WeekCamsirubicin Phase…
Dupixent® demonstrates potential to become first biologic to treat COPD by showing significant reduction in…
First and only biologic to demonstrate clinically meaningful and statistically significant reduction (30%) in exacerbations…
SOD1-ALS is a rare genetic form of the disease affecting approximately 330 people in the…
– SENTI-202 on track to submit an Investigational New Drug (IND) application in second half…
Collaboration between Project Management Institute and Women of Project Management to boost inclusion in the…
Fanatics currently makes and supplies Authentic Pro performance and training products for the NHL, and…
Dupixent® (dupilumab) approved by European Commission as first and only targeted medicine for children as…
Approximately seven times as many patients aged 6 months to 5 years with severe atopic…
Independent Research Firm report says Medallia “breaks away from competition with depth and breadth of…